Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/03/012644
CTRI/2018/03/012644
Completed
Phase 2

A Randomized Clinical End Point Study To Evaluate The Safety And Efficacy Of CLEARLIV Tablets In Patients With Alcoholic Liver Disease. - ALD

Apex Laboratories0 sites24 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Alcoholic Liver Disease patients

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Alcoholic Liver Disease patients
Sponsor
Apex Laboratories
Enrollment
24
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 16, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Apex Laboratories

Eligibility Criteria

Inclusion Criteria

  • •1\.Chronic alcohol intake patients
  • •2\.Serum AST \&ALT is typically elevated to a level of 2â??6 times the upper limits of the normal.
  • •3\.Negative pregnancy test for women in reproductive age (up to two weeks prior to the study)
  • •4\.Negative for hepatitis B and C

Exclusion Criteria

  • •1\.Patients who have liver disease with the cause different from that of alcohol induced liver disease.
  • •2\.Drug dependence
  • •3\.A known hypersensitivity or allergy to any component of the drugs evaluated in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
To Study The Effect Of Hingu Churna In Ovulationâ??Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
CTRI/2022/10/046207A
Not yet recruiting
Phase 2
The study of effect of Namaskaradi ointment in Fissure
CTRI/2020/11/029401Dr Deepali Anandrao Ahire
Not yet recruiting
Phase 2
The effect of Guduchi drops in Neonatal JaundiceHealth Condition 1: P599- Neonatal jaundice, unspecified
CTRI/2024/05/067467Dr. Sachin Rameshwar Bhagwat
Not yet recruiting
Phase 2
Evaluate the effect of modified kushthaghna kwath and tutthadi lepa in skin disorder(dadru kushtha)
CTRI/2022/07/043946ational Institute of Ayurveda Jaipur
Not yet recruiting
Phase 2
A Clinical Study to Evaluate the Efficacy of Duralabhadi Avleha in the Management of Vataja Kasa(Allergic Bronchitis) in ChildreHealth Condition 1: J40- Bronchitis, not specified as acuteor chronic
CTRI/2023/08/057155Parul Institute of Ayurved